These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7888049)

  • 1. A pharmacokinetic comparison of cyclosporin oral solution and cyclosporin capsules in heart and lung transplant recipients.
    Eadon H; Rose M; O'Neill R; Leaver N; Yacoub M
    Transpl Int; 1995; 8(1):35-40. PubMed ID: 7888049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
    Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
    Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.
    Belitsky P; Dunn S; Johnston A; Levy G
    Clin Pharmacokinet; 2000 Aug; 39(2):117-25. PubMed ID: 10976658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-guided strategies in drug development: experience with a cyclosporine analog in transplantation.
    Kovarik JM; Mueller EA; Kallay Z; Smith HT; Lison AE; Arns W; Renner E
    J Clin Pharmacol; 1995 Dec; 35(12):1136-43. PubMed ID: 8750363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis.
    Rousseau A; Monchaud C; Debord J; Vervier I; Estenne M; Thiry P; Marquet P
    Ther Drug Monit; 2003 Feb; 25(1):28-35. PubMed ID: 12548141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection.
    Jensen P; Lehne G; Fauchald P; Simonsen S
    Acta Derm Venereol; 1996 Jul; 76(4):280-1. PubMed ID: 8869684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin pharmacokinetics in paediatric transplant recipients.
    Cooney GF; Habucky K; Hoppu K
    Clin Pharmacokinet; 1997 Jun; 32(6):481-95. PubMed ID: 9195117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation.
    Mueller EA; Kovarik JM; van Bree JB; Lison AE; Kutz K
    Transplantation; 1994 Apr; 57(8):1178-82. PubMed ID: 8178343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
    Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
    Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients.
    Curtis JJ; Barbeito R; Pirsch J; Lewis RM; Van Buren DH; Choudhury S
    Am J Kidney Dis; 1999 Nov; 34(5):869-74. PubMed ID: 10561143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.
    Kahan BD; Welsh M; Schoenberg L; Rutzky LP; Katz SM; Urbauer DL; Van Buren CT
    Transplantation; 1996 Sep; 62(5):599-606. PubMed ID: 8830822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.